TTRX

Turn Therapeutics Inc.NASDAQHealthcare

$3.35+7.54%ClosedMarket Cap: $98.6M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

0.00

P/S

0.00

EV/EBITDA

-55.61

DCF Value

—

FCF Yield

-1.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3858.5%

ROA

-86.3%

ROIC

-130.1%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q2 2025	$0.00	NaN%	$-1.4M	$-1.2M	$0.00	—
FY 2024	$0.00	NaN%	$-1.8M	$-1.8M	$0.00	—
Q2 2024	$0.00	NaN%	$-360.2K	$-351.9K	$0.00	—
FY 2023	$0.00	NaN%	$-2.3M	$-2.3M	$0.00	—